nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—Application site pain—Dapsone—leprosy	0.0782	0.0888	CcSEcCtD
Lorazepam—Hypochromic anaemia—Thalidomide—leprosy	0.0454	0.0516	CcSEcCtD
Lorazepam—Hostility—Thalidomide—leprosy	0.0318	0.0361	CcSEcCtD
Lorazepam—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.0303	0.0344	CcSEcCtD
Lorazepam—TSPO—hindlimb—leprosy	0.0294	0.247	CbGeAlD
Lorazepam—TSPO—appendage—leprosy	0.0252	0.212	CbGeAlD
Lorazepam—Psychotic disorder—Dapsone—leprosy	0.0244	0.0277	CcSEcCtD
Lorazepam—Stupor—Thalidomide—leprosy	0.0236	0.0268	CcSEcCtD
Lorazepam—Apnoea—Thalidomide—leprosy	0.0208	0.0236	CcSEcCtD
Lorazepam—Thinking abnormal—Thalidomide—leprosy	0.0192	0.0218	CcSEcCtD
Lorazepam—Leukocytosis—Thalidomide—leprosy	0.0187	0.0213	CcSEcCtD
Lorazepam—Atrioventricular block—Thalidomide—leprosy	0.0182	0.0206	CcSEcCtD
Lorazepam—Hepatocellular injury—Thalidomide—leprosy	0.0176	0.02	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Thalidomide—leprosy	0.0176	0.02	CcSEcCtD
Lorazepam—Depressed level of consciousness—Thalidomide—leprosy	0.017	0.0193	CcSEcCtD
Lorazepam—Pulmonary oedema—Thalidomide—leprosy	0.0157	0.0178	CcSEcCtD
Lorazepam—Mental disability—Thalidomide—leprosy	0.0153	0.0173	CcSEcCtD
Lorazepam—Euphoric mood—Thalidomide—leprosy	0.0151	0.0172	CcSEcCtD
Lorazepam—Erythema—Dapsone—leprosy	0.015	0.0171	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.0147	0.0167	CcSEcCtD
Lorazepam—Vision blurred—Dapsone—leprosy	0.0142	0.0161	CcSEcCtD
Lorazepam—TSPO—blood vessel—leprosy	0.014	0.118	CbGeAlD
Lorazepam—Amnesia—Thalidomide—leprosy	0.0136	0.0154	CcSEcCtD
Lorazepam—Vertigo—Dapsone—leprosy	0.0135	0.0153	CcSEcCtD
Lorazepam—Visual disturbance—Thalidomide—leprosy	0.0135	0.0153	CcSEcCtD
Lorazepam—Lethargy—Thalidomide—leprosy	0.0131	0.0148	CcSEcCtD
Lorazepam—Hyponatraemia—Thalidomide—leprosy	0.0128	0.0146	CcSEcCtD
Lorazepam—Diplopia—Thalidomide—leprosy	0.0128	0.0145	CcSEcCtD
Lorazepam—Osteoarthritis—Thalidomide—leprosy	0.0128	0.0145	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.0128	0.0145	CcSEcCtD
Lorazepam—Psychotic disorder—Thalidomide—leprosy	0.0125	0.0142	CcSEcCtD
Lorazepam—Cardiac arrest—Thalidomide—leprosy	0.0122	0.0138	CcSEcCtD
Lorazepam—Ataxia—Thalidomide—leprosy	0.012	0.0136	CcSEcCtD
Lorazepam—Tachycardia—Dapsone—leprosy	0.012	0.0136	CcSEcCtD
Lorazepam—Liver function test abnormal—Thalidomide—leprosy	0.0118	0.0134	CcSEcCtD
Lorazepam—Pancytopenia—Thalidomide—leprosy	0.0105	0.0119	CcSEcCtD
Lorazepam—Erectile dysfunction—Thalidomide—leprosy	0.0102	0.0116	CcSEcCtD
Lorazepam—Drowsiness—Thalidomide—leprosy	0.00986	0.0112	CcSEcCtD
Lorazepam—Agranulocytosis—Thalidomide—leprosy	0.0092	0.0104	CcSEcCtD
Lorazepam—Bradycardia—Thalidomide—leprosy	0.00901	0.0102	CcSEcCtD
Lorazepam—Visual impairment—Thalidomide—leprosy	0.00853	0.00967	CcSEcCtD
Lorazepam—Chills—Thalidomide—leprosy	0.00794	0.00901	CcSEcCtD
Lorazepam—Arrhythmia—Thalidomide—leprosy	0.0079	0.00897	CcSEcCtD
Lorazepam—Alopecia—Thalidomide—leprosy	0.00782	0.00887	CcSEcCtD
Lorazepam—Vomiting—Dapsone—leprosy	0.00781	0.00886	CcSEcCtD
Lorazepam—Headache—Dapsone—leprosy	0.00769	0.00873	CcSEcCtD
Lorazepam—Tension—Thalidomide—leprosy	0.00756	0.00857	CcSEcCtD
Lorazepam—Nervousness—Thalidomide—leprosy	0.00748	0.00849	CcSEcCtD
Lorazepam—TSPO—eye—leprosy	0.00746	0.0629	CbGeAlD
Lorazepam—Nausea—Dapsone—leprosy	0.00729	0.00827	CcSEcCtD
Lorazepam—Vision blurred—Thalidomide—leprosy	0.00726	0.00824	CcSEcCtD
Lorazepam—Tremor—Thalidomide—leprosy	0.00722	0.00819	CcSEcCtD
Lorazepam—Agitation—Thalidomide—leprosy	0.00708	0.00803	CcSEcCtD
Lorazepam—Vertigo—Thalidomide—leprosy	0.00692	0.00785	CcSEcCtD
Lorazepam—GABRB3—eye—leprosy	0.00677	0.0571	CbGeAlD
Lorazepam—Convulsion—Thalidomide—leprosy	0.00667	0.00757	CcSEcCtD
Lorazepam—Hypertension—Thalidomide—leprosy	0.00665	0.00754	CcSEcCtD
Lorazepam—TSPO—skin of body—leprosy	0.00649	0.0547	CbGeAlD
Lorazepam—Dry mouth—Thalidomide—leprosy	0.00641	0.00728	CcSEcCtD
Lorazepam—Confusional state—Thalidomide—leprosy	0.00634	0.00719	CcSEcCtD
Lorazepam—Infection—Thalidomide—leprosy	0.00624	0.00708	CcSEcCtD
Lorazepam—Thrombocytopenia—Thalidomide—leprosy	0.00615	0.00698	CcSEcCtD
Lorazepam—Tachycardia—Thalidomide—leprosy	0.00613	0.00696	CcSEcCtD
Lorazepam—Hypotension—Thalidomide—leprosy	0.00587	0.00666	CcSEcCtD
Lorazepam—Somnolence—Thalidomide—leprosy	0.00559	0.00634	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Thalidomide—leprosy	0.00543	0.00616	CcSEcCtD
Lorazepam—Fatigue—Thalidomide—leprosy	0.00542	0.00615	CcSEcCtD
Lorazepam—Pain—Thalidomide—leprosy	0.00538	0.0061	CcSEcCtD
Lorazepam—Constipation—Thalidomide—leprosy	0.00538	0.0061	CcSEcCtD
Lorazepam—Feeling abnormal—Thalidomide—leprosy	0.00518	0.00588	CcSEcCtD
Lorazepam—TSPO—tendon—leprosy	0.00494	0.0416	CbGeAlD
Lorazepam—GABRG2—nervous system—leprosy	0.00475	0.04	CbGeAlD
Lorazepam—Hypersensitivity—Thalidomide—leprosy	0.00463	0.00525	CcSEcCtD
Lorazepam—Asthenia—Thalidomide—leprosy	0.00451	0.00512	CcSEcCtD
Lorazepam—GABRA1—nervous system—leprosy	0.00419	0.0353	CbGeAlD
Lorazepam—Dizziness—Thalidomide—leprosy	0.00416	0.00472	CcSEcCtD
Lorazepam—TSPO—testis—leprosy	0.00409	0.0345	CbGeAlD
Lorazepam—TSPO—nervous system—leprosy	0.00401	0.0338	CbGeAlD
Lorazepam—Vomiting—Thalidomide—leprosy	0.004	0.00453	CcSEcCtD
Lorazepam—Rash—Thalidomide—leprosy	0.00396	0.0045	CcSEcCtD
Lorazepam—Dermatitis—Thalidomide—leprosy	0.00396	0.00449	CcSEcCtD
Lorazepam—Headache—Thalidomide—leprosy	0.00394	0.00447	CcSEcCtD
Lorazepam—Nausea—Thalidomide—leprosy	0.00373	0.00424	CcSEcCtD
Lorazepam—GABRB3—testis—leprosy	0.00371	0.0313	CbGeAlD
Lorazepam—GABRB3—nervous system—leprosy	0.00364	0.0307	CbGeAlD
